INDIANAPOLIS — Imagine "Shark Tank," but all medical and life science companies pitching innovative life-saving ideas. It's exactly what Indiana University Launch Accelerator for Biosciences and ...
SNAP Biosciences, a subsidiary of Coeptis Therapeutics Holdings, has entered into a licensing agreement with Monarch Therapeutics to develop and commercialize its Snap-Car NK cell therapy platform for ...
INDIANAPOLIS (WISH) — Indiana University on Tuesday commenced construction on the IU Launch Accelerator for Biosciences, which is being called IU LAB, in the 16 Tech Innovation District. The goal of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback